Literature DB >> 16014068

The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.

Timothy W Meyer1, Jason L Walther, Maria Enrica Pagtalunan, Andres W Martinez, Ali Torkamani, Patrick D Fong, Natalie S Recht, Channing R Robertson, Thomas H Hostetter.   

Abstract

BACKGROUND: Hemofiltration in the form of continuous venovenous hemofiltration (CVVH) is increasingly used to treat acute renal failure. Compared to hemodialysis, hemofiltration provides high clearances for large solutes but its effect on protein-bound solutes has been largely ignored.
METHODS: Standard clinical systems were used to remove test solutes from a reservoir containing artificial plasma. Clearances of the protein-bound solutes phenol red (C(PR)) and indican (C(IN)) were compared to clearances of urea (C(UREA)) during hemofiltration and hemodiafiltration. A mathematical model was developed to predict clearances from values for plasma flow Q(p), dialysate flow Q(d), ultrafiltration rate Q(f), filter size and the extent of solute binding to albumin.
RESULTS: When hemofiltration was performed with Q(p) 150 mL/min and Q(f) 17 mL/min, clearance values were C(PR) 1.0 +/- 0.1 mL/min; C(IN) 3.7 +/- 0.5 mL/min; and C(UREA) 14 +/- 1 mL/min. The clearance of the protein-bound solutes was approximately equal to the solute-free fraction multiplied by the ultrafiltration rate corrected for the effect of predilution. Addition of Q(d) 42 mL/min to provide HDF while Q(p) remained 150 mL/min resulted in proportional increases in the clearance of protein-bound solutes and urea. In contrast, the clearance of protein-bound solutes relative to urea increased when hemodiafiltration was performed using a larger filter and increasing Q(d) to 300 mL/min while Q(p) was lowered to 50 mL/min. The pattern of observed results was accurately predicted by mathematical modeling.
CONCLUSION: In vitro measurements and mathematical modeling indicate that CVVH provides very limited clearance of protein-bound solutes. Continuous venous hemodiafiltration (CVVHDF) increases the clearance of protein-bound solutes relative to urea only when dialysate flow rate and filter size are increased above values now commonly employed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014068     DOI: 10.1111/j.1523-1755.2005.00469.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Staying on target with continuous dialysis.

Authors:  Sevag Demirjian; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-23       Impact factor: 8.237

2.  Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Authors:  Xue-Sen Cao; Jun Chen; Jian-Zhou Zou; Yi-Hong Zhong; Jie Teng; Jun Ji; Zhang-Wei Chen; Zhong-Hua Liu; Bo Shen; Yu-Xin Nie; Wen-Lv Lv; Fang-Fang Xiang; Xiao Tan; Xiao-Qiang Ding
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-20       Impact factor: 8.237

3.  Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique.

Authors:  Yuanyuan Shi; Huajun Tian; Yifeng Wang; Yue Shen; Qiuyu Zhu; Feng Ding
Journal:  Blood Purif       Date:  2021-08-16       Impact factor: 3.348

4.  Determinants of Hemodialysis Performance: Modeling Fluid and Solute Transport in Hollow-Fiber Dialyzers.

Authors:  Jian Yu; Vipul C Chitalia; Olukemi O Akintewe; Aurelie Edwards; Joyce Y Wong
Journal:  Regen Eng Transl Med       Date:  2019-11-25

5.  Tubular Secretion in CKD.

Authors:  Astrid M Suchy-Dicey; Thomas Laha; Andrew Hoofnagle; Rick Newitt; Tammy L Sirich; Timothy W Meyer; Ken E Thummel; N David Yanez; Jonathan Himmelfarb; Noel S Weiss; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

Review 6.  [Renal replacement therapy in the intensive care unit. Current aspects].

Authors:  T M Bingold; B Scheller; B Zwissler; H Wissing
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

7.  Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.

Authors:  Carolien M S Schophuizen; Martijn J Wilmer; Jitske Jansen; Lena Gustavsson; Constanze Hilgendorf; Joost G J Hoenderop; Lambert P van den Heuvel; Rosalinde Masereeuw
Journal:  Pflugers Arch       Date:  2013-06-29       Impact factor: 3.657

8.  Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators.

Authors:  Michal L Melamed; Laura Plantinga; Tariq Shafi; Rulan Parekh; Timothy W Meyer; Thomas H Hostetter; Josef Coresh; Neil R Powe
Journal:  BMC Nephrol       Date:  2013-06-27       Impact factor: 2.388

9.  Lactate clearance and metabolic aspects of continuous high-volume hemofiltration.

Authors:  Wisit Cheungpasitporn; Ladan Zand; John J Dillon; Qi Qian; Nelson Leung
Journal:  Clin Kidney J       Date:  2015-06-17

10.  Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis.

Authors:  Sunny Eloot; Daniel Schneditz; Tom Cornelis; Wim Van Biesen; Griet Glorieux; Annemie Dhondt; Jeroen Kooman; Raymond Vanholder
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.